Less than a year after Google’s intentions to purchase Israeli cybersecurity startup Wiz fell through, officials reached an agreement in a frenzy of discussions following the inauguration of US President Donald Trump eight weeks ago. Google increased its original offer of $23 billion in July to $32 billion, making it one of the most significant…

US equities were flat before the bell on Wednesday as investors awaited the Federal Reserve’s policy decision, hoping to get insight into the economy in the face of tariff worries. Futures for the Dow Jones Industrial Average (YM=F) and the S&P 500 (ES=F) remained near the flat line. Nasdaq 100 futures (NQ=F) were similarly slightly…

On March 19, a rate-setting panel led by US Fed Chair Jerome Powell will announce the US central bank’s second policy decision for 2025, despite widespread anticipation of an interest rate suspension due to economic uncertainties around tariffs. US Fed Policy: Despite the threat of “stagflation” to the most excellent economy in the world, the…

Following the board’s decision to prolong Rajivnayan Rahulkumar Bajaj’s term as Managing Director & Chief Executive Officer for another five years, beginning on April 1, shares of Bajaj Auto will be the subject of attention on Wednesday. Additionally, they have approved a maximum investment of Rs 1,500 crore into Bajaj Auto Credit, a firm subsidiary….

To give policymakers more time to assess the potential impact of increased U.S. tariffs on the export-dependent economy, Japan maintained interest rates at their current level on Wednesday. The decision was widely anticipated because of concerns about a global slowdown brought on by U.S. President Donald Trump’s tariff policies, which overshadowed wage and price statistics…

On Tuesday, March 18, pharmaceutical manufacturer Zydus Lifesciences Ltd. said that the (FDA) had permitted it to produce and purchase 60 mg of apalutamide, the generic version of 60 mg Erleada tablets. Patients with metastatic castration-sensitive prostate cancer may benefit from therapy with the androgen receptor inhibitor palutamide. At Zydus Lifesciences Ltd (SEZ), Ahmedabad, apalutamide…

On March 17, the Super Iron Foundry IPO allocation will be finalized. Investors can use Link Intime’s site to see their allocation status. With a subscription rate of 1.56 times by Day 3, the initial public offering (IPO) occurred between March 11 and 13. Super Iron Foundry IPO Allotment Date:  Today (Monday, March 17), the…